Medical professionals should carefully assess your medical history, preexisting conditions, and potential drug interactions
It is a distinct condition from simple dietary B12 shortfall, and it needs medical evaluation
This triple agonist design, developed by Eli Lilly under the research code LY3437943, represents a fundamentally different approach from semaglutide (which targets only GLP-1) or tirzepatide (which targets GLP-1 and GIP)
Combining B12 with lipotropic compounds or semaglutide injections can speed up fat loss for some individuals
Not for human consumption or medical application
The myelin sheath surrounds the axons of many nerves and serves as an electrical insulation, thereby facilitating fast conduction velocity because of this it was confirmed that Vitamin B12 promotes axon growth of neuronal cells after peripheral nerve injury, and therefore widely used for treatment of peripheral nerve damage in the clinical trials